Format

Send to

Choose Destination
J Biomol Screen. 2016 Feb;21(2):176-86. doi: 10.1177/1087057115608605. Epub 2015 Oct 1.

The Evolution of MALDI-TOF Mass Spectrometry toward Ultra-High-Throughput Screening: 1536-Well Format and Beyond.

Author information

1
Department of Biological Sciences, GlaxoSmithKline, Stevenage, UK.
2
Department of Chemical Sciences, GlaxoSmithKline, Stevenage, UK.
3
Bruker Daltonik GmbH, Bremen, Germany.
4
Department of Sample Management and Automation, GlaxoSmithKline, Stevenage, UK.
5
Department of Biological Sciences, GlaxoSmithKline, Stevenage, UK melanie.v.leveridge@gsk.com.

Abstract

Mass spectrometry (MS) offers a label-free, direct-detection method, in contrast to fluorescent or colorimetric methodologies. Over recent years, solid-phase extraction-based techniques, such as the Agilent RapidFire system, have emerged that are capable of analyzing samples in <10 s. While dramatically faster than liquid chromatography-coupled MS, an analysis time of 8-10 s is still considered relatively slow for full-diversity high-throughput screening (HTS). Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF) offers an alternative for high-throughput MS detection. However, sample preparation and deposition onto the MALDI target, as well as interference from matrix ions, have been considered limitations for the use of MALDI for screening assays. Here we describe the development and validation of assays for both small-molecule and peptide analytes using MALDI-TOF coupled with nanoliter liquid handling. Using the JMJD2c histone demethylase and acetylcholinesterase as model systems, we have generated robust data in a 1536 format and also increased sample deposition to 6144 samples per target. Using these methods, we demonstrate that this technology can deliver fast sample analysis time with low sample volume, and data comparable to that of current RapidFire assays.

KEYWORDS:

MALDI-TOF; RapidFire; high-throughput screening; mass spectrometry

PMID:
26428484
DOI:
10.1177/1087057115608605
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Atypon
Loading ...
Support Center